Filing Details
- Accession Number:
- 0001520138-23-000534
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-06 16:16:27
- Reporting Period:
- 2023-11-09
- Accepted Time:
- 2023-12-06 16:16:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1580149 | Biovie Inc. | BIVI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1033742 | Steve Gorlin | C/O Biovie Inc. 680 W Nye Lane Ste 201 Carson City NV 89703 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-09 | 46,358 | $0.00 | 122,038 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2023-12-01 | 75,680 | $1.69 | 46,358 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- The restricted stock unit ("RSU") grant was approved by the compensation committee of the issuer's board of directors on September 22, 2023, subject to board approval, which was obtained on November 9, 2023. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments beginning on February 9, 2024, with the remaining installments vesting on May 9, 2024, August 9, 2024 and the earlier of November 9, 2024 or the date of the issuer's 2024 annual shareholders' meeting.
Billionaire Hedge Funds
